ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Prostate cancer stem-like cells proliferate slowly and resist etoposide-induced cytotoxicity via enhancing DNA damage response

Yan Judy; Tang Damu*
Experimental Cell Research2014-10-15DOI: 10.1016/j.yexcr.2014.08.016
3阅读
引用收藏
分享

摘要

Despite the development of chemoresistance as a major concern in prostate cancer therapy, the underlying mechanisms remain elusive. In this report, we demonstrate that DU145-derived prostate cancer stem cells (PCSCs) progress slowly with more cells accumulating in the Cl phase in comparison to DU145 non-PCSCs. Consistent with the important role of the AKT pathway in promoting G1 progression, DU145 PCSCs were less sensitive to growth factor-induced activation of AKT in comparison to non-PCSCs. In response to etoposide (one of the most commonly used chemotherapeutic drugs), DU145 PCSCs survived significantly better than non-PCSCs. In addition to etoposide, PCSCs demonstrated increased resistance to docetaxel, a taxane drug that is commonly used to treat castration-resistant prostate cancer. Etoposide produced elevated levels of gamma H2AX and triggered a robust G2/M arrest along with a coordinated reduction of the G1 population in PCSCs compared to non-PCSCs, suggesting that elevated gamma H2AX plays a role in the resistance of PCSCs to etoposide-induced cytotoxicity. We have generated xenograft tumors from DU145 PCSCs and non-PCSCs. Consistent with the knowledge that PCSCs produce xenograft tumors with more advanced features, we were able to demonstrate that PCSC-derived xenograft tumors displayed higher levels of gamma H2AX and p-CHK1 compared to non-PCSC-produced xenograft tumors. Collectively, our research suggests that the elevation of DNA damage response contributes to PCSC-associated resistance to genotoxic reagents.

学科与关键词

关键词
Prostate cancer stem cellCell proliferationCell signalingDNA damage responseTumorigenesis
相关
加载中…
  • DNA damage response and resistance of cancer stem cells
    Etna Abad E; Dmitry Graifer; Alex LyakhovichCancer Letters, 2020.
  • CNTN-1 promotes docetaxel resistance and epithelial-to-mesenchymal transition via the PI3K/Akt signaling pathway in prostate cancer
    Chen, Binshen; Zhang, Yiming; Li, Chaoming; Xu, Peng; Gao, Yubo; Xu, Yawen*Archives of Medical Science, 2021, 17(1): 152-165.被引 16
  • Transcriptome analysis of differentially expressed genes and pathways associated with mitoxantrone treatment prostate cancer.
    Li, Sanqiang; Li, Ruifang; Ma, Yu; Zhang, Cong; Huang, Tao; Zhu, ShaJournal of Cellular and Molecular Medicine, 2019, 23(3): 1987-2000.
查看全部 →

发表信息

论文状态
公开发表
期刊
Experimental Cell Research
发表日期
2014-10-15
卷期
第 328 卷, 第 1 期
页码
132-142
DOI
10.1016/j.yexcr.2014.08.016
语言
MULTI-LANGUAGE
期刊收录
SCIE
期刊等级
Q2
成果收录
SCI
资助标注
CIHR [MOP - 84381]

作者

  • Y

    Yan Judy (第一作者)

  • T

    Tang Damu (通讯)

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417